Literature DB >> 33679403

Ginsenosides Improve Nonalcoholic Fatty Liver Disease via Integrated Regulation of Gut Microbiota, Inflammation and Energy Homeostasis.

Wenyi Liang1, Kun Zhou1, Ping Jian1, Zihao Chang1, Qiunan Zhang1, Yuqi Liu1, Shuiming Xiao2, Lanzhen Zhang1.   

Abstract

Ginseng, the root and rhizome of Panax ginseng C. A. Mey., is a famous herbal medicine, and its major ginsenosides exert beneficial effects on nonalcoholic fatty liver disease (NAFLD). Due to the multicomponent and multitarget features of ginsenosides, their detailed mechanisms remain unclear. This study aimed to explore the role of ginsenosides on NAFLD and the potential mechanisms mediated by the gut microbiota and related molecular processes. C57BL/6J mice were fed a high-fat diet (HFD) supplemented or not supplemented with ginsenoside extract (GE) for 12 weeks. A strategy that integrates bacterial gene sequencing, serum pharmacochemistry and network pharmacology was applied. The results showed that GE significantly alleviated HFD-induced NAFLD symptoms in a dose-dependent manner. Furthermore, GE treatment modulated the HFD-induced imbalance in the gut microbiota and alleviated dysbiosis-mediated gut leakage and metabolic endotoxemia. Additionally, 20 components were identified in the mouse plasma after the oral administration of GE, and they interacted with 82 NAFLD-related targets. A network analysis revealed that anti-inflammatory effects and regulation of the metabolic balance might be responsible for the effects of GE on NAFLD. A validation experiment was then conducted, and the results suggested that GE suppressed NF-κB/IκB signaling activation and decreased the release and mRNA levels of proinflammatory factors (TNF-α, IL-1β and IL-6). Additionally, GE promoted hepatic lipolytic genes (CPT-1a), inhibited lipogenic genes (SREBP-1c, FAS, ACC-1) and improved leptin resistance. These findings imply that the benefits of GE are involved in modulating the gut microbiota, enhancing the gut barrier function, restoring the energy balance, and alleviating metabolic inflammation. Moreover, GE might serve as a potential agent for the prevention of NAFLD through the integration of prebiotic, anti-inflammatory and energy-regulatory effects.
Copyright © 2021 Liang, Zhou, Jian, Chang, Zhang, Liu, Xiao and Zhang.

Entities:  

Keywords:  ginsenosides; gut microbiota; inflammation; network pharmacology; nonalcoholic fatty liver disease

Year:  2021        PMID: 33679403      PMCID: PMC7928318          DOI: 10.3389/fphar.2021.622841

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  7 in total

Review 1.  The Untapped Potential of Ginsenosides and American Ginseng Berry in Promoting Mental Health via the Gut-Brain Axis.

Authors:  Tristan St-Laurent; Riadh Hammami
Journal:  Nutrients       Date:  2022-06-17       Impact factor: 6.706

Review 2.  Chronic Inflammation-A Link between Nonalcoholic Fatty Liver Disease (NAFLD) and Dysfunctional Adipose Tissue.

Authors:  Maria Petrescu; Sonia Irina Vlaicu; Lorena Ciumărnean; Mircea Vasile Milaciu; Codruța Mărginean; Mira Florea; Ștefan Cristian Vesa; Monica Popa
Journal:  Medicina (Kaunas)       Date:  2022-05-06       Impact factor: 2.948

Review 3.  Gut Microbiota: Therapeutic Targets of Ginseng Against Multiple Disorders and Ginsenoside Transformation.

Authors:  Zhaoqiang Chen; Zepeng Zhang; Jiaqi Liu; Hongyu Qi; Jing Li; Jinjin Chen; Qingxia Huang; Qing Liu; Jia Mi; Xiangyan Li
Journal:  Front Cell Infect Microbiol       Date:  2022-04-25       Impact factor: 6.073

4.  Phyllanthus emblica aqueous extract retards hepatic steatosis and fibrosis in NAFLD mice in association with the reshaping of intestinal microecology.

Authors:  Xiaomin Luo; Boyu Zhang; Yehua Pan; Jian Gu; Rui Tan; Puyang Gong
Journal:  Front Pharmacol       Date:  2022-07-26       Impact factor: 5.988

5.  The interactions between traditional Chinese medicine and gut microbiota: Global research status and trends.

Authors:  Shanshan Yang; Shaodong Hao; Qin Wang; Yanni Lou; Liqun Jia; Dongmei Chen
Journal:  Front Cell Infect Microbiol       Date:  2022-09-12       Impact factor: 6.073

Review 6.  Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents.

Authors:  Daisuke Tokuhara
Journal:  Front Nutr       Date:  2021-06-25

Review 7.  Nutraceuticals and Herbal Food Supplements for Weight Loss: Is There a Prebiotic Role in the Mechanism of Action?

Authors:  Alexander Bertuccioli; Marco Cardinali; Marco Biagi; Sara Moricoli; Ilaria Morganti; Giordano Bruno Zonzini; Giovanna Rigillo
Journal:  Microorganisms       Date:  2021-11-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.